10x Genomics, Inc. Current Income Tax Expense (Benefit)
10x Genomics, Inc. (TXG) reported Current Income Tax Expense (Benefit) of $3.95 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-13
- 10x Genomics, Inc. current income tax expense (benefit) for fiscal 2025 was $3.95M, a 6.42% decline from fiscal 2024.
- 10x Genomics, Inc. current income tax expense (benefit) for fiscal 2024 was $4.22M, a 37.82% decline from fiscal 2023.
- 10x Genomics, Inc. current income tax expense (benefit) for fiscal 2023 was $6.78M, a 74.24% increase from fiscal 2022.
- 10x Genomics, Inc. current income tax expense (benefit) for fiscal 2022 was $3.89M, a 25.11% decline from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $3.95M 10-K · filed 2026-02-13 |
| 2024-12-31 | $4.22M 10-K · filed 2026-02-13 |
| 2023-12-31 | $6.78M 10-K · filed 2026-02-13 |
| 2022-12-31 | $3.89M 10-K · filed 2025-02-13 |
| 2021-12-31 | $5.20M 10-K · filed 2024-02-15 |
| 2020-12-31 | $8.17M 10-K · filed 2023-02-16 |
| 2019-12-31 | $224.00K 10-K · filed 2022-02-18 |